Migraine sufferers have new oral medication with FDA approval of Allergan's Ubrelvy

Ubrelvy is proven to ease migraine symptoms in two hours.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.